BioLineRx Total Assets 2012-2019 | BLRX

BioLineRx total assets from 2012 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
BioLineRx Annual Total Assets
(Millions of US $)
2018 $56
2017 $61
2016 $39
2015 $51
2014 $36
2013 $20
2012 $24
2011 $29
BioLineRx Quarterly Total Assets
(Millions of US $)
Q1 2019 $68
Q4 2018 $56
Q3 2018 $46
Q2 2018 $52
Q1 2018 $56
Q4 2017 $61
Q3 2017 $66
Q2 2017 $63
Q1 2017 $41
Q4 2016 $39
Q3 2016 $42
Q2 2016 $46
Q1 2016 $49
Q4 2015 $51
Q3 2015 $55
Q2 2015 $58
Q1 2015 $60
Q4 2014 $36
Q3 2014 $31
Q2 2014 $35
Q1 2014 $39
Q4 2013 $20
Q3 2013 $22
Q2 2013 $25
Q1 2013 $31
Q4 2012 $24
Q3 2012 $28
Q2 2012 $33
Q1 2012 $39
Q4 2011 $29
Q3 2011 $33
Q2 2011 $38
Q1 2011 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.041B $0.000B
Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $49.249B 31.47
Takeda Pharmaceutical (TAK) Japan $27.232B 8.00
Grifols (GRFS) Spain $12.383B 15.66
Ionis Pharmaceuticals (IONS) United States $9.421B 20.59
Sage Therapeutics (SAGE) United States $8.965B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.786B 10.67
Neurocrine Biosciences (NBIX) United States $7.189B 0.00
Catalent (CTLT) United States $6.731B 27.01
Nektar Therapeutics (NKTR) United States $5.764B 9.39
Tilray (TLRY) Canada $4.355B 0.00
United Therapeutics (UTHR) United States $3.767B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.732B 13.09
FibroGen (FGEN) United States $3.027B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.464B 8.87
PTC Therapeutics (PTCT) United States $2.302B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.083B 313.86
Portola Pharmaceuticals (PTLA) United States $2.008B 0.00
Tricida (TCDA) United States $1.861B 0.00
Xencor (XNCR) United States $1.859B 50.74
Enanta Pharmaceuticals (ENTA) United States $1.812B 24.77
Aerie Pharmaceuticals (AERI) United States $1.811B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.789B 86.66
USANA Health Sciences (USNA) United States $1.720B 14.95
Ironwood Pharmaceuticals (IRWD) United States $1.713B 0.00
Zogenix (ZGNX) United States $1.619B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.523B 0.00
Heron Therapeutics (HRTX) United States $1.404B 0.00
Endo (ENDP) Ireland $1.384B 2.23
Esperion Therapeutics (ESPR) United States $1.371B 0.00
Corcept Therapeutics (CORT) United States $1.204B 17.18
TURNING PT THER (TPTX) United States $1.197B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.025B 0.00
Radius Health (RDUS) United States $0.952B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.869B 0.00
ArQule (ARQL) United States $0.802B 0.00
Aptorum Group (APM) China $0.767B 0.00
TherapeuticsMD (TXMD) United States $0.743B 0.00
ChemoCentryx (CCXI) United States $0.673B 0.00
ORGANOGENESIS (ORGO) United States $0.651B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.624B 0.00
Akebia Therapeutics (AKBA) United States $0.620B 0.00
CannTrust Holdings (CTST) Canada $0.601B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.598B 0.00
Odonate Therapeutics (ODT) United States $0.591B 0.00
Dermira (DERM) United States $0.522B 0.00
GlycoMimetics (GLYC) United States $0.500B 0.00
Flexion Therapeutics (FLXN) United States $0.476B 0.00
Siga Technologies (SIGA) United States $0.471B 1.11
Translate Bio (TBIO) United States $0.469B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.469B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.443B 22.36
KalVista Pharmaceuticals (KALV) United States $0.408B 0.00
Mast Therapeutics (SVRA) United States $0.404B 0.00
Collegium Pharmaceutical (COLL) United States $0.394B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.391B 0.00
Forty Seven (FTSV) United States $0.381B 0.00
Karyopharm Therapeutics (KPTI) United States $0.371B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.359B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 0.00
OptiNose (OPTN) United States $0.337B 0.00
TCR2 Therapeutics (TCRR) United States $0.337B 0.00
Xeris Pharmaceuticals (XERS) United States $0.316B 0.00
CASI Pharmaceuticals (CASI) United States $0.302B 0.00
ImmunoGen (IMGN) United States $0.289B 0.00
Molecular Templates (MTEM) United States $0.286B 0.00
Dova Pharmaceuticals (DOVA) United States $0.282B 0.00
Harpoon Therapeutics (HARP) United States $0.268B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.264B 0.00
Concert Pharmaceuticals (CNCE) United States $0.263B 0.00
Lannett Co Inc (LCI) United States $0.239B 2.32
Aratana Therapeutics (PETX) United States $0.235B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.230B 0.00
Calithera Biosciences (CALA) United States $0.224B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.221B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.221B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.219B 0.00
MEI Pharma (MEIP) United States $0.217B 0.00
Rafael Holdings (RFL) United States $0.213B 0.00
Aclaris Therapeutics (ACRS) United States $0.208B 0.00
Recro Pharma (REPH) United States $0.206B 0.00
IMV INC (IMV) Canada $0.202B 0.00
Minerva Neurosciences (NERV) United States $0.201B 0.00
Aldeyra Therapeutics (ALDX) United States $0.196B 0.00
Opexa Therapeutics (ACER) United States $0.193B 0.00
Nature's Sunshine Products (NATR) United States $0.187B 60.56
Galectin Therapeutics (GALT) United States $0.183B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.173B 0.00
Ardelyx (ARDX) United States $0.171B 0.00
Redhill Biopharma (RDHL) Israel $0.167B 0.00
Majesco Entertainment (PTE) United States $0.165B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.149B 0.00
Neon Therapeutics (NTGN) United States $0.147B 0.00
Tyme Technologies (TYME) United States $0.143B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.140B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.136B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.134B 0.00
Bio Blast Pharma (ENLV) Israel $0.116B 0.00
Aquestive Therapeutics (AQST) United States $0.113B 0.00
MediWound (MDWD) Israel $0.111B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.106B 0.00
Nivalis Therapeutics (ALPN) United States $0.105B 0.00
Ocular Therapeutix (OCUL) United States $0.105B 0.00
AgeX Therapeutics (AGE) United States $0.103B 0.00
ProNAi Therapeutics (SRRA) Canada $0.102B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 71.11
Zafgen (ZFGN) United States $0.099B 0.00
DURECT (DRRX) United States $0.097B 0.00
Cardiome Pharma (CORV) Canada $0.096B 0.00
Natural Alternatives (NAII) United States $0.096B 9.57
China SXT Pharmaceuticals (SXTC) China $0.089B 0.00
Iterum Therapeutics (ITRM) Ireland $0.088B 0.00
Infinity Pharmaceuticals (INFI) United States $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Neos Therapeutics (NEOS) United States $0.081B 0.00
Avenue Therapeutics (ATXI) United States $0.079B 0.00
Otonomy (OTIC) United States $0.079B 0.00
ElectroCore (ECOR) United States $0.079B 0.00
Adherex Technologies (FENC) United States $0.078B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.071B 0.00
Capnia (SLNO) United States $0.068B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.068B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Genocea Biosciences (GNCA) United States $0.063B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.058B 0.00
Novan (NOVN) United States $0.058B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.057B 0.00
KemPharm (KMPH) United States $0.048B 0.00
CTI BioPharma (CTIC) United States $0.047B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
AIT Therapeutics (AITB) Israel $0.045B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.042B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.042B 0.00
India Globalization Capital (IGC) United States $0.042B 0.00
Bio-Path Holdings (BPTH) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
Lipocine (LPCN) United States $0.039B 0.00
Melinta Therapeutics (MLNT) United States $0.033B 0.00
PharmAthene (ALT) United States $0.033B 0.00
ContraFect (CFRX) United States $0.033B 0.00
ProPhase Labs (PRPH) United States $0.032B 0.00
IsoRay (ISR) United States $0.031B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.029B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Regulus Therapeutics (RGLS) United States $0.027B 0.00
HANCOCK JAFFE (HJLI) United States $0.027B 0.00
Heat Biologics (HTBX) United States $0.025B 0.00
Achieve Life Sciences (ACHV) United States $0.025B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.022B 2.95
Tokai Pharmaceuticals (NVUS) United States $0.022B 0.00
NanoViricides (NNVC) United States $0.020B 0.00
Onconova Therapeutics (ONTX) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Pain Therapeutics (SAVA) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.017B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
Shineco (TYHT) China $0.016B 2.73
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.007B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.006B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.000B 0.00